HEATHER KMIECIK: Open Payments
NPI 1508405853 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 71 payments from 24 companies in 2025. Trend: 2023 $140 · 2024 $778 · 2025 $1,603
Food & beverage: $1,603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $380 |
| Vanda Pharmaceuticals Inc. | 8 | $175 |
| Amgen Inc. | 13 | $141 |
| Abbott Laboratories | 1 | $140 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
| Novo Nordisk Inc | 4 | $73 |
| Lilly USA, LLC | 4 | $65 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| SANOFI-AVENTIS U.S. LLC | 2 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
Products named: VRAYLAR, FANAPT, FREESTYLE LIBRE 3, QULIPTA, OTEZLA, ZENPEP, MOUNJARO, Auvelity.
Industry payments across IN — which companies pay providers there.
